Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma

		Keywords:		NCT00576641

		Phase:		Phase 1

		Treatment ID#s:		VT1841 Vaccine

		Age Group:		Adult And Pediatric

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: Y Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		03/02/2008

		Tumor Types:		Brainstem Glioma Glioblastoma Multiforme


		Comments:

		Treatment Type:		Immunological, Biological or Targeted Therapy.

		Contact:		Cedars-Sinai Maxine Dunitz Neurosurgical Institute Surasak Phuphanich, MD 8631 W Third St Los Angeles, CA 90048 Phone:310-423-7900 Click here to send an email Website: www.cedars-sinai.edu/mdnsi

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By